Massachusetts Financial Services CO Meridian Bioscience Inc Transaction History

Massachusetts Financial Services CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$23.75 - $31.69 $243,152 - $324,442	-10,238 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$19.97 - $26.94 $1.92 Million - $2.58 Million	-95,949 Reduced 90.36%	10,238 $266,000
Q4 2021 Feb 10, 2022	SELL	$17.46 - $21.61 $315,170 - $390,082	-18,051 Reduced 14.53%	106,187 $2.17 Million
Q3 2021 Nov 10, 2021	SELL	$17.35 - $22.5 $28,280 - $36,675	-1,630 Reduced 1.3%	124,238 $2.39 Million
Q2 2021 Aug 13, 2021	BUY	$18.01 - $28.32 $829,378 - $1.3 Million	46,051 Added 57.7%	125,868 $2.79 Million
Q1 2021 May 13, 2021	SELL	$19.76 - $29.89 $186,909 - $282,729	-9,459 Reduced 10.6%	79,817 $2.1 Million
Q4 2020 Feb 12, 2021	BUY	$15.73 - $21.66 $614,240 - $845,801	39,049 Added 77.75%	89,276 $1.67 Million
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $680,073 - $1.33 Million	50,227 New	50,227 $853,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.